摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,5-bis[4-chlorophenylmethylidene]thiocarbonohydrazide | 6340-16-5

中文名称
——
中文别名
——
英文名称
1,5-bis[4-chlorophenylmethylidene]thiocarbonohydrazide
英文别名
N,N-bis[(4-chlorophenyl)methylidene]carbothioic dihydrazide;N,2-Bis[(4-chlorophenyl)methylidene]hydrazine-1-carbohydrazonothioic acid;1,3-bis[(4-chlorophenyl)methylideneamino]thiourea
1,5-bis[4-chlorophenylmethylidene]thiocarbonohydrazide化学式
CAS
6340-16-5
化学式
C15H12Cl2N4S
mdl
——
分子量
351.259
InChiKey
IMPWGGGRTFHXJR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.5
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    80.9
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    1,5-bis[4-chlorophenylmethylidene]thiocarbonohydrazide 在 iron(III) chloride 、 lithium perchlorate 作用下, 以 乙醇 为溶剂, 反应 0.5h, 生成 2-(5-methyl-3-(4-chlorophenyl)-1H-[1,2,4]triazol-1-yl)-5-(4-chlorophenyl)-1,3,4-thiadiazole 、 3,6-Di(4-chlorophenyl)-s-triazolo<3,4-b><1,3,4>thiadiazole
    参考文献:
    名称:
    Anodic formation of 3,6-diaryl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and 2(3-aryl-5-methyl-1H-[1,2,4]triazol-1-yl)-5-aryl-1,3,4-thiadiazoles
    摘要:
    3,6-Disubstituted 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles together with the unknown systems 2-(3-aryl-5-methyl-1H-[1,2,4]triazol-1-yl)-5-aryl-1,3,4-thiadiazoles were obtained by anodic oxidation, under aprotic conditions, of aryl aldehyde N-(5-aryl-1,3,4-thiadiazol-2-yl) hydrazones. Mechanistic proposals are given. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2011.02.084
  • 作为产物:
    参考文献:
    名称:
    微波辅助方法设计和合成新型噻唑类药物:作为抗乳腺癌药物的评价和分子对接研究
    摘要:
    摘要 通过硫代碳酰肼、醛与取代苯甲酰溴的微波辅助多组分反应,设计并合成了一系列新型噻唑类似物。所有合成化合物的结构与它们的光谱(1H 和 13C NMR、FTIR、Mass)和分析数据非常吻合。通过针对 MCF-7、MDA-MB-231/ATCC、HS 578 T、BT-549、T-47D 和 MDA-MB-468 乳腺癌细胞系的测试,筛选了目标噻唑化合物的体外细胞毒活性。从体外结果发现化合物4b对MDA-MB-231/ATCC细胞系具有强活性。还对这些化合物进行了对接研究,以探查可能的结合位点相互作用,这与体外结果很好地证实了。图形概要
    DOI:
    10.1080/00397911.2020.1781184
点击查看最新优质反应信息

文献信息

  • Synthesis of Thiocarbohydrazones and Evaluation of their in vitro Antileishmanial Activity
    作者:Munira T. Muhammad、Nida Ghouri、Khalid M. Khan、Arshia、Muhammad I. Choudhary、Shahnaz Perveen
    DOI:10.2174/1573406414666180115094630
    日期:2018.10.3
    Background: Leishmaniasis is a protozoan parasitic vector-borne disease which is endemic in 88 tropical countries. Infected sandfly is the main vector of this disease, while there are several other vectors, parasites, and reservoirs involved in the transmission of this disease. Leishmania donovani, L. infantum, and L. chagasi are common disease causing species, transmitted through sandflies. Leishmaniasis is a neglected tropical disease with broad spectrum of clinical manifestations. Cutaneous leishmaniasis is prevalent in many countries, including Pakistan. Methods: Thiocarbohydrazones (1-20) were synthesized through one pot method by refluxing thiocarbahydrazide with different substituted benzaldehydes in ethanol in the presence of acetic acid as a catalyst. These synthetic compounds were evaluated for their potential antileishmanial activity in vitro against Leishmania major promastigotes. Results: Compounds 5-8, 11, 14, 16, 17, 19 and 20 were reported earlier, while compounds 2-4, 9, 10, 12, 13 and 15 were identified as were derivatives. Compounds 1-20 demonstrated antileishmanial activities with IC50 values between 1.63 ± 0.05 - 64.82 ± 0.17 µM, as compared to the standard drug pentamidine (IC50 = 5.09 ± 0.04 µM). Compounds 2 (IC50 = 1.63 ± 0.05 µM), 11 (IC50 = 2.33 ± 0.01 µM), 4 (IC50 = 11.03 ± 0.20 µM), and 10 (IC50 = 11.63 ± 0.06 µM) displayed comparable antileishmanial activities to the standard drug pentamidine. However, compounds 13, 15-17, and 20 with IC50 values 36.95 ± 0.025, 64.82 ± 0.17, 64.27 ± 0.38, 62.34 ± 0.38, and 40.47 ± 0.05 µM, respectively, showed a moderate antileishmanial activity. In contrast, compounds 1, 3, 5-9, 12, 14, 18, and 19 demonstrated less than 50% growth inhibition of promestigotes of L. major, and thus considered as inactive. Conclusion: In thiocarbohydrazone derivatives, different substituents at aryl part may be responsible for a varying degree of antileishmanial activity in vitro. Consequently, these compounds might have a potential for further studies as a new class of antileishmanial agents.
    背景:利什曼病是一种原生动物寄生虫病媒传染病,在 88 个热带国家流行。受感染的沙蝇是这种疾病的主要传播媒介,同时还有其他几种传播媒介、寄生虫和储库参与这种疾病的传播。 唐氏利什曼原虫、婴儿利什曼原虫和查加斯利什曼原虫是常见的致病物种,通过沙蝇传播。利什曼病是一种被忽视的热带疾病,具有广泛的临床表现。皮肤利什曼病在包括巴基斯坦在内的许多国家都很流行。 方法:在乙酸作为催化剂的存在下,通过一锅法将代酰与不同取代的苯甲醛乙醇中回流合成了代酰(1-20)。结果:化合物 5-8、11、14、16、17、19 和 20 早先已有报道,而化合物 2-4、9、10、12、13 和 15 则被鉴定为衍生物。与标准药物喷他脒(IC50 = 5.09 ± 0.04 µM)相比,化合物 1-20 具有抗利什曼病活性,IC50 值介于 1.63 ± 0.05 - 64.82 ± 0.17 µM。化合物 2(IC50 = 1.63 ± 0.05 µM)、11(IC50 = 2.33 ± 0.01 µM)、4(IC50 = 11.03 ± 0.20 µM)和 10(IC50 = 11.63 ± 0.06 µM)显示出与标准药物喷他脒相当的抗利什曼活性。然而,IC50 值分别为 36.95 ± 0.025、64.82 ± 0.17、64.27 ± 0.38、62.34 ± 0.38 和 40.47 ± 0.05 µM 的化合物 13、15-17 和 20 显示出中等程度的抗利什曼病活性。结论:在代羧生物中,芳基部分的不同取代基可能是体外抗利什曼活性不同的原因。因此,这些化合物可能有潜力作为一类新的抗利什曼病药进行进一步研究。
  • Synthesis of Novel Triazoles, Tetrazine, Thiadiazoles and Their Biological Activities
    作者:Mohammed Al-Omair、Abdelwahed Sayed、Magdy Youssef
    DOI:10.3390/molecules20022591
    日期:——
    An expedient synthesis of novel triazoles, tetrazine and thiadiazoles, using conveniently accessible and commercially available starting materials has been achieved. The synthesized compounds were characterized by spectroscopic and elemental analyses, and screened for their antibacterial activities against four different strains, namely E. coli, P. aeruginosa, S. aureus and B. megaterium. In particular, the compounds 5, 24 and 26h exhibited excellent antibacterial activities compared to the reference antibiotic. To get further insight about their behavior, these compounds were tested for their antioxidant activities via SOD-like activity, DPPH free radical scavenging activity, ABST and NO, which showed promising results. Furthermore, these compounds effectively promoted the cleavage of genomic DNA as well, in the absence of any external additives.
    利用方便易得的市售起始材料,实现了新型三唑、四杂嗪和噻二唑的快速合成。通过光谱和元素分析对合成的化合物进行了表征,并筛选了它们对四种不同菌株(即大肠杆菌、绿假单胞菌、黄色葡萄球菌和巨大芽孢杆菌)的抗菌活性。与参考抗生素相比,化合物 5、24 和 26h 尤其表现出卓越的抗菌活性。为了进一步了解这些化合物的行为,研究人员通过 SOD 样活性、DPPH 自由基清除活性、ABST 和 NO 测试了它们的抗化活性。此外,在没有任何外部添加剂的情况下,这些化合物还能有效促进基因组 DNA 的裂解。
  • Novel Synthesis of Oxothiazolidine Derivatives
    作者:Alaa A. Hassan、Yusria R. Ibrahim、Essmat M. El-Sheref、Alan B. Brown
    DOI:10.1002/jhet.935
    日期:2012.9
    (Z)‐Methyl 2‐[3‐(arylideneamino)‐2‐(arylidenehydrazono)‐4‐oxothiazolidin‐5‐ylidene]acetate prepared during the reaction between thiocarbonohydrazides and dimethyl acetylene dicarboxylate. Rational for there conversations involving the nucleophilic addition on C/C triple bond of dimethyl acetylenedicarboxylate are presented.
    (Z)-2-与二甲基乙炔二甲反应时制得的2- [3-(3-亚芳基基)-2-(芳基亚杂基)-4-噻唑啉--5-亚苄基]乙酸。提出了有关乙炔羧酸二甲的C / C三键亲核加成的讨论的合理性。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫